MTRR rs1801394 and its interaction with MTHFR rs1801133 in colorectal cancer: a case–control study and meta-analysis-Reference-Cited by-同舟云学术

MTRR rs1801394 and its interaction with MTHFR rs1801133 in colorectal cancer: a case–control study and meta-analysis

Published:2017-07 Issue:11 Volume:18 Page:1075-1084
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Haerian Monir Sadat¹²,Haerian Batoul Sadat¹,Molanaei Saadat³,Kosari Farid⁴,Sabeti Shahram⁵,Bidari-Zerehpoosh Farahnaz⁵,Abdolali Ebrahim⁶

Affiliation:

1. Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Bone & Joint Reconstruction Research Center, Shafa Yahyaeian Orthopedics Hospital, Iran University of Medical Science, Tehran, Iran

3. Department of Pathology, Milad Hospital, Tehran, Iran

4. Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Pathology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

6. Department of Pathology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Aim: This study aims to evaluate the association between the MTRR rs1801394 alone or in interaction with the MTHFR rs1801133 and susceptibility to colorectal cancer (CRC) and its characteristics in Iranian population. Additionally, both a systematic review and meta-analysis were performed to derive a more precise assessment of this association. Materials & methods: Genomic DNA of 2332 subjects was genotyped for rs1801394. These data were pooled with 17 eligible studies for meta-analysis. Results: No significant association was found between the rs1801394 or rs1801394-rs1801133 and CRC risk. Meta-analysis results also demonstrated no significant relationship between the rs1801394 and CRC risk. Conclusion: Results of this study showed that the rs1801394 alone or together with the rs1801133 is not a risk factor for CRC in Iranian population.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2017-0030

Reference36 articles.

1. Folate-genetics and colorectal neoplasia: What we know and need to know next

2. Folate, colorectal cancer and the involvement of DNA methylation

3. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria

4. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Roles of MTRR and MTHFR Gene Polymorphisms in Colorectal Cancer Survival;Nutrients;2022-11-01

2. Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancer;World Journal of Clinical Cases;2022-05-16